EP4011909 - HIGH AFFINITY T-CELL RECEPTOR CAPABLE OF IDENTIFYING NY-ESO-1 ANTIGEN [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.02.2024 Database last updated on 19.10.2024 | |
Former | Request for examination was made Status updated on 13.05.2022 | ||
Former | The international publication has been made Status updated on 12.02.2021 | Most recent event Tooltip | 09.02.2024 | Application deemed to be withdrawn | published on 13.03.2024 [2024/11] | Applicant(s) | For all designated states XLifeSc, Ltd. Office 2715, No. 3000, Huandao East Road Hengqin New District Zhuhai, Guangdong 519031 / CN | [2022/24] | Inventor(s) | 01 /
LI, Yi Building No.1, No. 2 Jinfengyuan Road Science City, High-Tech Hub Guangzhou, Guangdong 510663 / CN | 02 /
CHEN, Liang Building No.1, No. 2 Jinfengyuan Road Science City, High-Tech Hub Guangzhou, Guangdong 510663 / CN | 03 /
LI, Xiaolin Building No.1, No. 2 Jinfengyuan Road Science City, High-Tech Hub Guangzhou, Guangdong 510663 / CN | [2022/24] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [2022/24] | Application number, filing date | 20849609.1 | 31.07.2020 | [2022/24] | WO2020CN106291 | Priority number, date | CN201910713184 | 02.08.2019 Original published format: CN201910713184 | [2022/24] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021023116 | Date: | 11.02.2021 | Language: | ZH | [2021/06] | Type: | A1 Application with search report | No.: | EP4011909 | Date: | 15.06.2022 | Language: | EN | [2022/24] | Search report(s) | International search report - published on: | CN | 11.02.2021 | (Supplementary) European search report - dispatched on: | EP | 02.03.2023 | Classification | IPC: | C07K14/725, C12N15/12, C12N15/63, C12N15/10, A61K38/17, A61P35/00 | [2022/24] | CPC: |
A61P35/00 (EP,CN);
C07K14/7051 (EP,CN,US);
A61K35/17 (EP,CN,US);
A61K39/4611 (EP,CN,US);
A61K39/4632 (EP,CN,US);
A61K39/464488 (EP,CN,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/24] | Title | German: | HOCHAFFINER T-ZELL-REZEPTOR ZUR IDENTIFIZIERUNG VON NY-ESO-1-ANTIGEN | [2022/24] | English: | HIGH AFFINITY T-CELL RECEPTOR CAPABLE OF IDENTIFYING NY-ESO-1 ANTIGEN | [2022/24] | French: | RÉCEPTEUR DE SLYMPHOCYTES T DE HAUTE AFFINITÉ CAPABLE D'IDENTIFIER L'ANTIGÈNE NY-ESO-1 | [2022/24] | Entry into regional phase | 02.03.2022 | Translation filed | 02.03.2022 | National basic fee paid | 02.03.2022 | Search fee paid | 02.03.2022 | Designation fee(s) paid | 02.03.2022 | Examination fee paid | Examination procedure | 02.03.2022 | Amendment by applicant (claims and/or description) | 02.03.2022 | Examination requested [2022/24] | 03.10.2023 | Application deemed to be withdrawn, date of legal effect [2024/11] | 24.10.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/11] | Fees paid | Renewal fee | 02.03.2022 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.07.2023 | 04   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]CN106632660 (XIANGXUE PHARMACEUTICAL CO LTD); | [X]WO2017076308 (GUANGZHOU XIANGXUE PHARMACEUTICAL CO LTD [CN]); | [X]CN108117596 (GUANGDONG XIANGXUE PRECISION MEDICAL TECH CO LTD); | [X]WO2018099402 (GUANGDONG XIANGXUE LIFE SCIENCES LTD [CN]) |